New Enterprise Associates 11 Lp - Net Worth and Insider Trading
New Enterprise Associates 11 Lp Net Worth
The estimated net worth of New Enterprise Associates 11 Lp is at least $394 Million dollars as of 2024-05-05. New Enterprise Associates 11 Lp is the 10% Owner of Supernus Pharmaceuticals Inc and owns about 10,641,250 shares of Supernus Pharmaceuticals Inc (SUPN) stock worth over $328 Million. New Enterprise Associates 11 Lp is the 10% Owner of Amicus Therapeutics Inc and owns about 4,584,311 shares of Amicus Therapeutics Inc (FOLD) stock worth over $48 Million. New Enterprise Associates 11 Lp is also the 10% Owner of InnerWorkings Inc and owns about 6,029,190 shares of InnerWorkings Inc (INWK) stock worth over $18 Million. Besides these, New Enterprise Associates 11 Lp also holds Tableau Software Inc (DATA) . Details can be seen in New Enterprise Associates 11 Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that New Enterprise Associates 11 Lp has not made any transactions after 2013-11-20 and currently still holds the listed stock(s).
Transaction Summary of New Enterprise Associates 11 Lp
New Enterprise Associates 11 Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, New Enterprise Associates 11 Lp owns 5 companies in total, including Supernus Pharmaceuticals Inc (SUPN) , Tableau Software Inc (DATA) , and Xoom Corp (XOOM) among others .
Click here to see the complete history of New Enterprise Associates 11 Lp’s form 4 insider trades.
Insider Ownership Summary of New Enterprise Associates 11 Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SUPN | Supernus Pharmaceuticals Inc | 2012-05-04 | 10 percent owner |
| DATA | Tableau Software Inc | 2014-12-02 | 10 percent owner |
| XOOM | Xoom Corp | 2013-10-29 | 10 percent owner |
 | | 2012-03-28 | 10 percent owner |
| | 2012-03-07 | 10 percent owner |
New Enterprise Associates 11 Lp Latest Holdings Summary
New Enterprise Associates 11 Lp currently owns a total of 4 stocks. Among these stocks, New Enterprise Associates 11 Lp owns 10,641,250 shares of Supernus Pharmaceuticals Inc (SUPN) as of May 4, 2012, with a value of $328 Million and a weighting of 83.31%. New Enterprise Associates 11 Lp owns 4,584,311 shares of Amicus Therapeutics Inc (FOLD) as of March 7, 2012, with a value of $48 Million and a weighting of 12.11%. New Enterprise Associates 11 Lp also owns 6,029,190 shares of InnerWorkings Inc (INWK) as of February 29, 2012, with a value of $18 Million and a weighting of 4.58%. The other 1 stocks Tableau Software Inc (DATA) have a combined weighting of 0% among all his current holdings.
Latest Holdings of New Enterprise Associates 11 Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SUPN | Supernus Pharmaceuticals Inc | 2012-05-04 | 10,641,250 | 30.83 | 328,069,738 |
| FOLD | Amicus Therapeutics Inc | 2012-03-07 | 4,584,311 | 10.40 | 47,676,834 |
| INWK | InnerWorkings Inc | 2012-02-29 | 6,029,190 | 2.99 | 18,027,278 |
| DATA | Tableau Software Inc | 2013-11-20 | 0 | 169.53 | 0 |
Holding Weightings of New Enterprise Associates 11 Lp
New Enterprise Associates 11 Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, New Enterprise Associates 11 Lp has made a total of 0 transactions in Supernus Pharmaceuticals Inc (SUPN) over the past 5 years. The most-recent trade in Supernus Pharmaceuticals Inc is the acquisition of 4,400,000 shares on May 4, 2012, which cost New Enterprise Associates 11 Lp around $22 Million.
According to the SEC Form 4 filings, New Enterprise Associates 11 Lp has made a total of 0 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years. The most-recent trade in Amicus Therapeutics Inc is the acquisition of 925,154 shares on March 7, 2012, which cost New Enterprise Associates 11 Lp around $5 Million.
According to the SEC Form 4 filings, New Enterprise Associates 11 Lp has made a total of 0 transactions in InnerWorkings Inc (INWK) over the past 5 years. The most-recent trade in InnerWorkings Inc is the sale of 455,360 shares on February 29, 2012, which brought New Enterprise Associates 11 Lp around $5 Million.
More details on New Enterprise Associates 11 Lp's insider transactions can be found in the Insider Trading History of New Enterprise Associates 11 Lp table.Insider Trading History of New Enterprise Associates 11 Lp
- 1
New Enterprise Associates 11 Lp Trading Performance
GuruFocus tracks the stock performance after each of New Enterprise Associates 11 Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by New Enterprise Associates 11 Lp is 39.57%. GuruFocus also compares New Enterprise Associates 11 Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by New Enterprise Associates 11 Lp within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how New Enterprise Associates 11 Lp's insider trading performs compared to the benchmark.
Performance of New Enterprise Associates 11 Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -11.06 | | | | | |
| Relative Return to S&P 500(%) | -9.42 | | | | | |
New Enterprise Associates 11 Lp Ownership Network
New Enterprise Associates 11 Lp Owned Company Details
What does Supernus Pharmaceuticals Inc do?
Who are the key executives at Supernus Pharmaceuticals Inc?
New Enterprise Associates 11 Lp is the 10 percent owner of Supernus Pharmaceuticals Inc. Other key executives at Supernus Pharmaceuticals Inc include Sr. VP of IP & CSO Padmanabh P. Bhatt , Sr. V.P. & Regulatory Affairs Tami Tillotson Martin , and Sr VP & Quality & GMP Oper. & IT Frank Mottola .
Supernus Pharmaceuticals Inc (SUPN) Insider Trades Summary
Over the past 18 months, New Enterprise Associates 11 Lp made no insider transaction in Supernus Pharmaceuticals Inc (SUPN). Other recent insider transactions involving Supernus Pharmaceuticals Inc (SUPN) include a net sale of 116,005 shares made by Padmanabh P. Bhatt , a net sale of 76,390 shares made by Jack A. Khattar , and a net sale of 21,235 shares made by Tami Tillotson Martin .
In summary, during the past 3 months, insiders sold 98,505 shares of Supernus Pharmaceuticals Inc (SUPN) in total and bought 0 shares, with a net sale of 98,505 shares. During the past 18 months, 231,113 shares of Supernus Pharmaceuticals Inc (SUPN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 231,113 shares.
Supernus Pharmaceuticals Inc (SUPN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Supernus Pharmaceuticals Inc Insider Transactions
New Enterprise Associates 11 Lp Mailing Address
Above is the net worth, insider trading, and ownership report for New Enterprise Associates 11 Lp. You might contact New Enterprise Associates 11 Lp via mailing address: 1119 St. Paul St., Baltimore Md 21202.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
